← Eichor
Study identifier: NCT05920252 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

A Digitally Assisted Risk Reduction Platform for Youth at High Risk for Suicide

Condition: Suicide · Mental Health Disorder · Anhedonia  ·  Sponsor: Ksana Health

PhaseNA
Planned participants78
Who can joinAll sexes, 13 Years to 18 Years
Healthy volunteersNo

About this study

Despite efforts to prevent suicide, US rates are climbing, and suicide is the second leading cause of death among youth. Digital tools, especially personal smartphones, are promising avenues to address these issues and can be used to provide a unique understanding of risk factors, including psychological distress, anhedonia and behavioral withdrawal, and sleep disturbance among high-risk individuals. This project aims to enhance the effectiveness of the delivery of preventative health care to youth at risk for suicide by developing a comprehensive digital platform that allows practitioners to integrate mobile sensing data and HIPAA-compliant client communication tools into their management of these young people.

This description comes directly from the study's public registry record.

Talk to the study team

Randy Auerbach, PhD, ABPP  ·  646-774-5745  ·  rpa2009@cumc.columbia.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Columbia UniversityNew York, New York, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05920252